A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911 (Englisch)
- Neue Suche nach: Yamada, Kazuhiko
- Neue Suche nach: Aono, Hiromi
- Neue Suche nach: Hosomi, Yukio
- Neue Suche nach: Okamoto, Hiroaki
- Neue Suche nach: Kato, Terufumi
- Neue Suche nach: Komase, Yuko
- Neue Suche nach: Nishikawa, Masanori
- Neue Suche nach: Azuma, Koichi
- Neue Suche nach: Takeoka, Hiroaki
- Neue Suche nach: Okuma, Yusuke
- Neue Suche nach: Nakahara, Yoshiro
- Neue Suche nach: Sato, Akira
- Neue Suche nach: Oba, Mari S.
- Neue Suche nach: Morita, Satoshi
- Neue Suche nach: Kunitoh, Hideo
- Neue Suche nach: Watanabe, Koshiro
- Neue Suche nach: Yamada, Kazuhiko
- Neue Suche nach: Aono, Hiromi
- Neue Suche nach: Hosomi, Yukio
- Neue Suche nach: Okamoto, Hiroaki
- Neue Suche nach: Kato, Terufumi
- Neue Suche nach: Komase, Yuko
- Neue Suche nach: Nishikawa, Masanori
- Neue Suche nach: Azuma, Koichi
- Neue Suche nach: Takeoka, Hiroaki
- Neue Suche nach: Okuma, Yusuke
- Neue Suche nach: Nakahara, Yoshiro
- Neue Suche nach: Sato, Akira
- Neue Suche nach: Oba, Mari S.
- Neue Suche nach: Morita, Satoshi
- Neue Suche nach: Kunitoh, Hideo
- Neue Suche nach: Watanabe, Koshiro
In:
European journal of cancer
;
51
, 14
;
1904-1910
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911
-
Beteiligte:Yamada, Kazuhiko ( Autor:in ) / Aono, Hiromi ( Autor:in ) / Hosomi, Yukio ( Autor:in ) / Okamoto, Hiroaki ( Autor:in ) / Kato, Terufumi ( Autor:in ) / Komase, Yuko ( Autor:in ) / Nishikawa, Masanori ( Autor:in ) / Azuma, Koichi ( Autor:in ) / Takeoka, Hiroaki ( Autor:in ) / Okuma, Yusuke ( Autor:in )
-
Erschienen in:European journal of cancer ; 51, 14 ; 1904-1910
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:7 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 51, Ausgabe 14
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1857
-
^9^0Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesPicozzi, V.J. / Ramanathan, R.K. / Lowery, M.A. / Ocean, A.J. / Mitchel, E.P. / O'Neil, B.H. / Guarino, M.J. / Conkling, P.R. / Cohen, S.J. et al. | 2015
- 1865
-
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumoursPiha-Paul, S.A. / Munster, P.N. / Hollebecque, A. / Argiles, G. / Dajani, O. / Cheng, J.D. / Wang, R. / Swift, A. / Tosolini, A. et al. | 2015
- 1874
-
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancerFarolfi, A. / Scarpi, E. / Rocca, A. / Mangia, A. / Biglia, N. / Gianni, L. / Tienghi, A. / Valerio, M.R. / Gasparini, G. et al. | 2015
- 1882
-
MRI and intraoperative pathology to predict nipple-areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomyPonzone, R. / Maggiorotto, F. / Carabalona, S. / Rivolin, A. / Pisacane, A. / Kubatzki, F. / Renditore, S. / Carlucci, S. / Sgandurra, P. et al. | 2015
- 1890
-
Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitorsBrier, Moriah J. / Chambless, Dianne / Gross, Robert / Su, H. Irene / DeMichele, Angela / Mao, Jun J. et al. | 2015
- 1897
-
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsRakha, E. / Pajares, M.J. / Ilie, M. / Pio, R. / Echeveste, J. / Hughes, E. / Soomro, I. / Long, E. / Idoate, M.A. et al. | 2015
- 1904
-
A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911Yamada, Kazuhiko / Aono, Hiromi / Hosomi, Yukio / Okamoto, Hiroaki / Kato, Terufumi / Komase, Yuko / Nishikawa, Masanori / Azuma, Koichi / Takeoka, Hiroaki / Okuma, Yusuke et al. | 2015
- 1911
-
PanGen-Fam: Spanish registry of hereditary pancreatic cancerMocci, E. / Guillen-Ponce, C. / Earl, J. / Marquez, M. / Solera, J. / Salazar-López, M.-T. / Calcedo-Arnáiz, C. / Vázquez-Sequeiros, E. / Montans, J. / Muñoz-Beltrán, M. et al. | 2015
- 1918
-
Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancerSylvie, Lorenzen / Silvia, Spoerl / Salah-Eddin, Al-Batran / Markus, Feith / Florian, Lordick / Peter, Thuss-Patience / Bernhard, Haller / Martin, Angele / Alexander, Novotny et al. | 2015
- 1927
-
Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)Heinemann, Volker / Stintzing, Sebastian / Modest, Dominik P. / Giessen-Jung, Clemens / Michl, Marlies / Mansmann, Ulrich R. et al. | 2015
- 1937
-
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic targetGo, H. / Kim, P.J. / Jeon, Y.K. / Cho, Y.M. / Kim, K. / Park, B.H. / Ku, J.Y. et al. | 2015
- 1946
-
Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancerLoriot, Y. / Eymard, J.C. / Patrikidou, A. / Ileana, E. / Massard, C. / Albiges, L. / Di Palma, M. / Escudier, B. / Fizazi, K. et al. | 2015
- 1953
-
CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinomaAn, Huimin / Xu, Le / Chang, Yuan / Zhu, Yu / Yang, Yuanfeng / Chen, Lian / Lin, Zongming / Xu, Jiejie et al. | 2015
- 1962
-
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapyShiota, Masaki / Fujimoto, Naohiro / Yokomizo, Akira / Takeuchi, Ario / Itsumi, Momoe / Inokuchi, Junichi / Tatsugami, Katsunori / Uchiumi, Takeshi / Naito, Seiji et al. | 2015
- 1970
-
The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancerIacovelli, R. / Verri, E. / Cossu Rocca, M. / Aurilio, G. / Cullura, D. / De Cobelli, O. / Nole, F. et al. | 2015
- 1978
-
Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, K. / Hasegawa, K. / Yoshino, K. / Murakami, R. / Hisamatsu, T. / Stone, R.L. / Previs, R.A. / Hansen, J.M. / Ikeda, Y. et al. | 2015
- 1989
-
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineStratigos, Alexander / Garbe, Claus / Lebbe, Celeste / Malvehy, Josep / del Marmol, Veronique / Pehamberger, Hubert / Peris, Ketty / Becker, Jürgen C. / Zalaudek, Iris / Saiag, Philippe et al. | 2015
- 2008
-
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemiaStumpel, D.J.P.M. / Schneider, P. / Pieters, R. / Stam, R.W. et al. | 2015
- 2022
-
Carboplatin therapeutic monitoring in preterm and full-term neonatesVeal, G.J. / Errington, J. / Hayden, J. / Hobin, D. / Murphy, D. / Dommett, R.M. / Tweddle, D.A. / Jenkinson, H. / Picton, S. et al. | 2015
- 2031
-
Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trialSchoot, R.A. / van Ommen, C.H. / Stijnen, T. / Tissing, W.J.E. / Michiels, E. / Abbink, F.C.H. / Raphael, M.F. / Heij, H.A. / Lieverst, J.A. et al. | 2015
- 2039
-
Trends in survival for teenagers and young adults with cancer in the UK 1992-2006O'Hara, C. / Moran, A. / Whelan, J.S. / Hough, R.E. / Stiller, C.A. / Stevens, M.C.G. / Stark, D.P. / Feltbower, R.G. / McCabe, M.G. et al. | 2015
- 2049
-
Unmet needs and depression among carers of people newly diagnosed with cancerHeckel, L. / Fennell, K.M. / Reynolds, J. / Osborne, R.H. / Chirgwin, J. / Botti, M. / Ashley, D.M. / Livingston, P.M. et al. | 2015
- 2058
-
A review of breast cancer awareness among women in India: Cancer literate or awareness deficit?Gupta, A. / Shridhar, K. / Dhillon, P.K. et al. | 2015
- 2067
-
Similar anatomical distributions of childhood naevi and cutaneous melanoma in young adults residing in northern and southern SwedenKarlsson, M.A. / Rodvall, Y. / Wahlgren, C.F. / Wiklund, K. / Lindelof, B. et al. | 2015
- 2076
-
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemiaPereira, João Kleber Novais / Machado-Neto, João Agostinho / Lopes, Matheus Rodrigues / Morini, Beatriz Corey / Traina, Fabiola / Costa, Fernando Ferreira / Saad, Sara Teresinha Olalla / Favaro, Patricia et al. | 2015
- 2086
-
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabValpione, S. / Martinoli, C. / Fava, P. / Mocellin, S. / Campana, L.G. / Quaglino, P. / Ferrucci, P.F. / Pigozzo, J. / Astrua, C. / Testori, A. et al. | 2015
- 2095
-
Comment on: Holscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7van Rossum, P.S.N. / Goense, L. / van Hillegersberg, R. / Ruurda, J.P. et al. | 2015
- 2095
-
Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950–7van Rossum, Peter S.N. / Goense, Lucas / van Hillegersberg, Richard / Ruurda, Jelle P. et al. | 2015
- 2097
-
Reply to the Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950–7Bollschweiler, Elfriede / Hölscher, Arnulf H. et al. | 2015
- 2097
-
Reply to the Comment on: Holscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7Bollschweiler, E. / Holscher, A.H. et al. | 2015